Abstract The present invention relates to controlled release formulations comprising an alpha-adrenergic receptor antagonist. More particularly, the present invention relates to controlled release matrix formulation comprising alfuzosin hydrochloride and a combination of HYDROPHILIC and hydrophobic polymers prepared by direct compression.